U.S. Army, FDA, CDC Refuse to Cooperate with Florida's COVID-19 Vaccine Safety and Efficacy Investigation
U.S. Army, FDA, CDC Refuse to Cooperate with Florida's COVID-19 Vaccine Safety and Efficacy Investigation
"[O]ur investigative efforts have been met with fulsome cooperation," the Florida grand jury stated.
A Florida grand jury, convened by Republican Governor Ron DeSantis to investigate the efficacy of COVID-19 vaccines, revealed on Friday that several federal agencies have declined to cooperate with their inquiries.
Follow Jon Fleetwood on Instagram @realjonfleetwood / Twitter @JonMFleetwood
The panel’s interim report, spanning 33 pages, shed light on the reluctance of witnesses to participate, citing alleged potential “professional or personal consequences” and questioning the fairness of the investigation.
You can download the full report here:
According to the report, federal agencies involved in the vaccine rollout, including the Center for Disease Control (CDC), the Food & Drug Administration (FDA), and the U.S. Army, have not provided the requested information to the grand jury.
“Unfortunately, not all our investigative efforts have been met with fulsome cooperation,” the grand jury report stated.
“Some prospective witnesses have elected not to testify, often citing potential professional or personal consequences arising from their involvement with the Statewide Grand Jury process.”
Florida’s Governor DeSantis initiated the grand jury in December 2022 to investigate potential wrongdoing and violations of state law by COVID vaccine manufacturers.
The jury, sworn in on June 26, 2023, has refrained from drawing conclusions on vaccine efficacy in its interim report.
“As of today, our investigation is nowhere near complete,” the report emphasized. “We remain in regular session and our Legal Advisor is actively scheduling future witness appearances.”
While the grand jury’s focus has primarily been on vaccine-related matters, its report also criticized health agencies and the federal government's handling of pandemic-era policies such as face masking and lockdowns.
“With respect to masks, we have never had sound evidence of their effectiveness against SARS-CoV-2 transmission,” the report noted. “Public health agencies failed to adequately explain” the ineffectiveness of masks to Americans.
Furthermore, the grand jury found that lockdown measures disproportionately affected certain demographics, favoring older, affluent individuals who could afford to stay home while potentially harming younger, less affluent groups:
“If anything, the result of this was a modest benefit to the former group at the expense of the latter.”
Follow Jon Fleetwood on Instagram @realjonfleetwood / Twitter @JonMFleetwood
Florida Surgeon General Called for Halt in Use of COVID mRNA Vaccines Citing DNA Damage
Last month, Florida State Surgeon General Dr. Joseph A. Ladapo called for a halt in the state’s use of mRNA coronavirus vaccines, citing safety concerns related to the discovery of billions of DNA fragments per dose of the Pfizer and Moderna COVID-19 mRNA vaccines:
“The FDA’s response does not provide data or evidence that the DNA integration assessments they recommended themselves have been performed. Instead, they pointed to genotoxicity studies – which are inadequate assessments for DNA integration risk. In addition, they obfuscated the difference between the SV40 promoter/enhancer and SV40 proteins, two elements that are distinct,” Ladapo said.
“DNA integration poses a unique and elevated risk to human health and to the integrity of the human genome, including the risk that DNA integrated into sperm or egg gametes could be passed onto offspring of mRNA COVID-19 vaccine recipients. If the risks of DNA integration have not been assessed for mRNA COVID-19 vaccines, these vaccines are not appropriate for use in human beings.”
“Providers concerned about patient health risks associated with COVID-19 should prioritize patient access to non-mRNA COVID-19 vaccines and treatment. It is my hope that, in regard to COVID-19, the FDA will one day seriously consider its regulatory responsibility to protect human health, including the integrity of the human genome.”
In December, Ladapo had raised significant concerns to the FDA and CDC regarding the safety and efficacy of the jabs.
The letter, addressed to FDA Commissioner Robert M. Califf and CDC Director Mandy Cohen emphasized the discovery of DNA fragments in the Pfizer and Moderna COVID-19 mRNA vaccines.
Dr. Ladapo’s letter reflects a deep concern about the “presence of nucleic acid contaminants in the approved Pfizer and Moderna COVID-19 mRNA vaccines,” particularly in the context of their lipid nanoparticle delivery systems.
Follow Jon Fleetwood on Instagram @realjonfleetwood / Twitter @JonMFleetwood
The letter reasons that because lipid nanoparticles are said to be an efficient vehicle for the delivery of COVID vaccines into human cells, they might “therefore be an equally efficient vehicle for delivering contaminant DNA into human cells.”
The Surgeon General expressed his apprehension about the potential risks of these DNA fragments.
He specifically referred to the Simian Virus 40 (SV40) promoter/enhancer DNA, noting that the “presence of SV40 promoter/enhancer DNA may also pose a unique and heightened risk of DNA integration into host cells.”
In his correspondence, Dr. Ladapo referenced FDA guidance from 2007 concerning DNA vaccines, highlighting the potential impacts of DNA integration on human health.
“DNA integration could theoretically impact a human’s oncogenes—the genes which can transform a healthy cell into a cancerous cell,” he quoted from the FDA document. “DNA integration may result in chromosomal instability.”
The letter posed several critical questions to the FDA and CDC, including whether drug manufacturers have evaluated the risk of human genome integration or mutagenesis from residual DNA contaminants in the vaccines:
“Have drug manufacturers evaluated the risk of human genome integration or mutagenesis of residual DNA contaminants from the mRNA COVID-19 vaccines alongside the additional risk of DNA integration from the lipid nanoparticle delivery system and SV40 promoter/enhancer? Has FDA inquired any information from the drug manufacturers to investigate such risk?”
The letter also asked: “Considering the potentially wide biodistribution of mRNA COVID-19 vaccines and DNA contaminants beyond the local injection site, have you evaluated the risk of DNA integration in reproductive cells with respect to the lipid nanoparticle delivery system?”
Given the widespread administration of these vaccines, Dr. Ladapo stressed the need for a swift response, requesting a written reply by December 13, 2023, to address both his previous letter and the concerns raised in the current one.
“The American people and the scientific community have a right to have all relevant information pertaining to the COVID-19 vaccines to properly inform individual decision-making,” he stated, emphasizing the urgency and importance of transparent communication on these matters.
Follow Jon Fleetwood on Instagram @realjonfleetwood / Twitter @JonMFleetwood